Quantification of macrophage migration inhibitory factor mRNA expression in non-small cell lung cancer tissues and its clinical significance

Makiko Tomiyasu, Ichiro Yoshino, Ryuichi Suemitsu, Tatsuro Okamoto, Keizo Sugimachi

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Purpose: Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine derived from T cells and the pituitary gland. However, several types of solid cancers also secrete MIF, and this factor has been suggested to play an important role in carcinogenesis and the progression of malignancy. In this study, we quantified MIF mRNA expression of non-small cell lung cancer tissues and examined its relationship with clinicopathological factors. Experimental Design: MIF mRNAs of both tumor and normal tissues were quantified by a real-time monitoring reverse-transcription PCR in 59 patients with non-small cell lung cancer. The relationship between the grade of MIF expression and clinicopathological factors such as smoking history, cell type, stage, and prognosis was examined to investigate the clinical significance of intratumoral expression of MIF. Results: The mean copy number of MIF mRNA per 0.08 μg of total mRNA in tumor tissues was 144,078.00, whereas that of normal lung tissue was 25,438.46 (P < 0.0001). The amounts of MIF proteins revealed by a Western blot analysis correlated well with those of the corresponding mRNAs. Male patients and heavy smokers showed significantly higher expression of MIF. Patients with squamous cell carcinomas showed a higher expression of MIF mRNA than other subjects. In squamous cell carcinoma patients, higher expression of MIF mRNA was significantly associated with unfavorable prognosis (P = 0.0142). Conclusions: The general intratumoral expression and close relation with smoking suggested that MIF might contribute to tumorigenesis in the lung.

Original languageEnglish
Pages (from-to)3755-3760
Number of pages6
JournalClinical Cancer Research
Volume8
Issue number12
Publication statusPublished - Dec 1 2002

Fingerprint

Macrophage Migration-Inhibitory Factors
Non-Small Cell Lung Carcinoma
Messenger RNA
Squamous Cell Carcinoma
Neoplasms
Carcinogenesis
Smoking
Lung
Pituitary Gland
Reverse Transcription
Research Design
Western Blotting
History
Cytokines
T-Lymphocytes
Polymerase Chain Reaction

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Quantification of macrophage migration inhibitory factor mRNA expression in non-small cell lung cancer tissues and its clinical significance. / Tomiyasu, Makiko; Yoshino, Ichiro; Suemitsu, Ryuichi; Okamoto, Tatsuro; Sugimachi, Keizo.

In: Clinical Cancer Research, Vol. 8, No. 12, 01.12.2002, p. 3755-3760.

Research output: Contribution to journalArticle

Tomiyasu, Makiko ; Yoshino, Ichiro ; Suemitsu, Ryuichi ; Okamoto, Tatsuro ; Sugimachi, Keizo. / Quantification of macrophage migration inhibitory factor mRNA expression in non-small cell lung cancer tissues and its clinical significance. In: Clinical Cancer Research. 2002 ; Vol. 8, No. 12. pp. 3755-3760.
@article{eaa935f0121e4401a79d20423999c4da,
title = "Quantification of macrophage migration inhibitory factor mRNA expression in non-small cell lung cancer tissues and its clinical significance",
abstract = "Purpose: Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine derived from T cells and the pituitary gland. However, several types of solid cancers also secrete MIF, and this factor has been suggested to play an important role in carcinogenesis and the progression of malignancy. In this study, we quantified MIF mRNA expression of non-small cell lung cancer tissues and examined its relationship with clinicopathological factors. Experimental Design: MIF mRNAs of both tumor and normal tissues were quantified by a real-time monitoring reverse-transcription PCR in 59 patients with non-small cell lung cancer. The relationship between the grade of MIF expression and clinicopathological factors such as smoking history, cell type, stage, and prognosis was examined to investigate the clinical significance of intratumoral expression of MIF. Results: The mean copy number of MIF mRNA per 0.08 μg of total mRNA in tumor tissues was 144,078.00, whereas that of normal lung tissue was 25,438.46 (P < 0.0001). The amounts of MIF proteins revealed by a Western blot analysis correlated well with those of the corresponding mRNAs. Male patients and heavy smokers showed significantly higher expression of MIF. Patients with squamous cell carcinomas showed a higher expression of MIF mRNA than other subjects. In squamous cell carcinoma patients, higher expression of MIF mRNA was significantly associated with unfavorable prognosis (P = 0.0142). Conclusions: The general intratumoral expression and close relation with smoking suggested that MIF might contribute to tumorigenesis in the lung.",
author = "Makiko Tomiyasu and Ichiro Yoshino and Ryuichi Suemitsu and Tatsuro Okamoto and Keizo Sugimachi",
year = "2002",
month = "12",
day = "1",
language = "English",
volume = "8",
pages = "3755--3760",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "12",

}

TY - JOUR

T1 - Quantification of macrophage migration inhibitory factor mRNA expression in non-small cell lung cancer tissues and its clinical significance

AU - Tomiyasu, Makiko

AU - Yoshino, Ichiro

AU - Suemitsu, Ryuichi

AU - Okamoto, Tatsuro

AU - Sugimachi, Keizo

PY - 2002/12/1

Y1 - 2002/12/1

N2 - Purpose: Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine derived from T cells and the pituitary gland. However, several types of solid cancers also secrete MIF, and this factor has been suggested to play an important role in carcinogenesis and the progression of malignancy. In this study, we quantified MIF mRNA expression of non-small cell lung cancer tissues and examined its relationship with clinicopathological factors. Experimental Design: MIF mRNAs of both tumor and normal tissues were quantified by a real-time monitoring reverse-transcription PCR in 59 patients with non-small cell lung cancer. The relationship between the grade of MIF expression and clinicopathological factors such as smoking history, cell type, stage, and prognosis was examined to investigate the clinical significance of intratumoral expression of MIF. Results: The mean copy number of MIF mRNA per 0.08 μg of total mRNA in tumor tissues was 144,078.00, whereas that of normal lung tissue was 25,438.46 (P < 0.0001). The amounts of MIF proteins revealed by a Western blot analysis correlated well with those of the corresponding mRNAs. Male patients and heavy smokers showed significantly higher expression of MIF. Patients with squamous cell carcinomas showed a higher expression of MIF mRNA than other subjects. In squamous cell carcinoma patients, higher expression of MIF mRNA was significantly associated with unfavorable prognosis (P = 0.0142). Conclusions: The general intratumoral expression and close relation with smoking suggested that MIF might contribute to tumorigenesis in the lung.

AB - Purpose: Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine derived from T cells and the pituitary gland. However, several types of solid cancers also secrete MIF, and this factor has been suggested to play an important role in carcinogenesis and the progression of malignancy. In this study, we quantified MIF mRNA expression of non-small cell lung cancer tissues and examined its relationship with clinicopathological factors. Experimental Design: MIF mRNAs of both tumor and normal tissues were quantified by a real-time monitoring reverse-transcription PCR in 59 patients with non-small cell lung cancer. The relationship between the grade of MIF expression and clinicopathological factors such as smoking history, cell type, stage, and prognosis was examined to investigate the clinical significance of intratumoral expression of MIF. Results: The mean copy number of MIF mRNA per 0.08 μg of total mRNA in tumor tissues was 144,078.00, whereas that of normal lung tissue was 25,438.46 (P < 0.0001). The amounts of MIF proteins revealed by a Western blot analysis correlated well with those of the corresponding mRNAs. Male patients and heavy smokers showed significantly higher expression of MIF. Patients with squamous cell carcinomas showed a higher expression of MIF mRNA than other subjects. In squamous cell carcinoma patients, higher expression of MIF mRNA was significantly associated with unfavorable prognosis (P = 0.0142). Conclusions: The general intratumoral expression and close relation with smoking suggested that MIF might contribute to tumorigenesis in the lung.

UR - http://www.scopus.com/inward/record.url?scp=0036898615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036898615&partnerID=8YFLogxK

M3 - Article

C2 - 12473586

AN - SCOPUS:0036898615

VL - 8

SP - 3755

EP - 3760

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 12

ER -